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7Abstract
Since the discovery of the first antibiotics, they have been a cornerstone of medical
treatment for bacterial infections. With the evolution of resistance to these existing
agents, it is becoming increasingly important to find novel antibiotics to maintain
the level of care of modern medicine.
The Small World Initiative created at Yale University aims to tackle this problem
by crowdsourcing the study of antibiotics that may be present in soil and sediment
in different environments. According to the Small World Initiative, over two thirds
of antibiotics originate from soil bacteria or fungi.
We aim to characterize the bacteria in soil obtained from Radium Springs, GA and
analyze their metabolic products for antibiotic activity against Staphylococcus aureus
and Acinetobacter baumannii under various conditions of environmental stress. This
site was chosen because we hypothesized that the presence of trace amounts of
radium in the natural water supply may give the local biome unique characteristics.
We isolated bacteria from soil samples collected from several locations with differing
levels of moisture. The isolates were co-cultured with S. aureus and A. baumannii
(our “tester” strains). We also exposed our tester strains to the metabolites from
the soil bacteria to determine if antibiotic activity was inherent to the soil bacteria
even without the presence of the target bacteria.
Our research did not find any significant antibiotic activity from the metabolites
of our soil bacteria against S. aureus or A. baumannii. Further tests should be
conducted on these samples with different methodologies that may induce the pro-
duction of other metabolites or varying levels of the same metabolites.
81 Introduction
Less than three years after the discovery of penicillin, researchers had already iden-
tified naturally occurring penicillinase1. It has been known for almost a century
that bacteria can develop resistance to antibiotics; however, the growth in resistant
species was moderate until the late 1980’s. Starting in approximately 1989, the
number of β-lactamase enzymes reported began an exponential growth, which may
have contributed to the increased awareness of this problem.
Penicillin was thought to be a cure for all Staphylococcus aureus infections until
more penicillinases were discovered. This led to a push in research into antibiotics
tailored for certain pathogens, such as methicillin2. However, in less than three
years after the discovery of methicillin, strains of S. aureus were already found that
had developed resistance against it3. This was the beginning of methicillin-resistant
S. aureus (MRSA), one of the “superbugs” that has received much media coverage
in recent years.
MRSA was first detected in nosocomial infections. It is thought that the increased
use of methicillin in hospitals contributed to a selective pressure for resistant strains
to thrive4. Selective pressures may allow bacteria that already harbor resistant genes
(r genes) to thrive relative to their counterparts without a similar r gene, though
there may be other selective pressures involved5.
Acinetobacter baumannii is thought to have had many r genes, and it also evolves
quickly in reaction to its environment3. This leads to intrinsic resistance, where a
species develops genes of resistance over time which remain in their genome, though
they many not always be expressed. However, this is not the only reported method
by which A. baumannii develops resistance. It is also capable of horizontal gene
transfer through transformation, which allow the bacterium to obtain r genes from
its environment and incorporate them into their own genome6. This combined ability
to obtain r genes from external factors and rapid evolution allows A. baumannii to
develop resistance to new drugs quickly3.
1.1 Mechanisms of Transfer of Antibiotic Resistance
Resistance is developed either intrinsically or obtained from external factors. How-
ever, any meaningful spread in resistance, whether by horizontal or vertical transfer,
requires that a selective pressure is present to make resistant cells more viable (or
non-resistant cells less viable). In the last few decades, commercial use of antibiotics
in the clinic, agriculture, and meat production has created this artificial selective
pressure. This is perhaps the reason for the exponential growth in reported number
of β-lactamase genes during the same time period. Although antibiotics are often
9overused in the clinic as well as the laboratory, perhaps most surprising is that over
80% of antibiotics (by weight) in use today are used in agriculture—specifically, on
cattle7,8.
While a large portion of antibiotics are used in agriculture, it is still important to
consider the effects of clinical over-prescription of these drugs, which may potentially
be the root producer of “superbugs” in hospitals. Of course, the problem does not lie
completely with physicians—some of whom feel pressured by their patients to write
prescriptions that may not be needed. According to one publication, a survey of
1,000 physicians found that 55% had prescribed antibiotics simply to coerce patients
into leaving surgery after treatment9.
Due to the prevalence of antibiotics in the clinic as well as in industry, we are fast
approaching a time when many of our drugs will be rendered obsolete for certain
strains of bacteria, some of which are ubiquitous. The way researchers have begun
approaching the search for novel agents is to chemically design molecules that will
function in the ways that existing antibiotics work–while being immune to degrada-
tion enzymes that give these microbes their resistance. An alternative approach is
to search for novel agents present in nature that have not yet been discovered, as
proposed by the Small World Initiative. However, it may be possible to narrow down
the search by looking at the mechanisms of action of currently available antibiotics.
1.2 Mechanisms of Action of Common Antibiotics
Antibiotics can be categorized into two over-arching groups based on their effect on
target strains. Bactericidal antibiotics kill the bacteria they target (and many of
those that they do not target), while bacteriostatic antibiotics simply prevent further
replication of the bacteria they target (and some they do not target). Because of
the growth in resistant bacteria, multiple antibiotics are sometimes administered
to increase the likelihood of curing a patient. For example, enterococci species
are becoming very difficult to treat with a single drug, so a multi-drug therapy is
common10–12.
Antibiotics can also be categorized by their specific mechanism of action by which
they have their desired effect on the bacteria. Some antibiotics, such as β-lactams
(e.g. penicillin), prevent synthesis of new cell walls. Other antibiotics work upstream
by preventing synthesis of proteins, some of which may be vital for the bacterium’s
survival. These antibiotics can be categorized as either bactericidal or bacteriostatic,
depending on whether they target cell mechanisms responsible for survival, or repli-
cation. Those that target mechanisms required for survival are bactericidal, while
those that target replication machinery are bacteriostatic. The last major category
of antibiotic drugs works by preventing DNA or RNA repair and replication13.
1.2.1 Cell-Wall Inhibitors
Perhaps the most commonly known cell-wall inhibiting antibiotic is penicillin, a
drug in the β-lactam class of antibiotics. This class of antibiotics was initially ef-
fective only against Gram-positive species, which have a thick peptidoglycan cell
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wall surrounding their cell membrane (Gram-negative bacteria, conversely, have an
inner and outer cell membrane, between which there is a relatively thin layer of pep-
tidoglycan and a periplasmic space). It is this peptidoglycan layer that β-lactamase
antibiotics disrupt14. Many of the early β-lactams are not effective against Gram-
negative bacteria because they use different transpeptidases for crosslinking of their
peptidoglycan layer. However, starting with the production of ampicillin and other
broad-spectrum β-lactam antibiotics, there was some activity against Gram-negative
species as well14.
The peptidoglycan layer in both types of bacteria is made up of chains of alternat-
ing N-acetyl-glucosamine (NAG) and N-acetyl-muramic acid (NAM). These chains
are crosslinked to one another using a transpeptidase enzyme. The enzymes cova-
lently link peptides composed of L-lysine, L/D-alanine, and D-glutamate located
on the NAM residues of the peptidoglycan layer. Penicillin and other β-lactams
covalently bind with the transpeptidases (also known as penicillin-binding proteins)
and prevent their proper function, thereby disrupting the crosslinking process of
new peptidoglycan polymers15. The various antibiotics in the β-lactam class have
different affinities for the various penicillin-binding proteins (PBPs) naturally found
in bacteria, so each antibiotic can be effective against a slightly different spectrum
of bacterial species16.
Figure 1.1: ß-lactam mechanism of action versus glycopeptides mechanism
of action. Top: ß-lactam antibiotics bind to the transpeptidase enzyme
preventing its action in crosslinking cell wall peptidoglycans. Bottom:
Glycopeptides directly bind the peptidoglycans in the cell wall to prevent
crosslinking.
Glycopeptide antibiotics, such as vancomycin, have a similar effect on the cell walls
of Gram-positive bacteria, though their mechanism of action is different. Rather
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than binding with the transpeptidase enzymes that catalyze crosslinking of peptido-
glycan polymers, glycopeptide antibiotics directly bind the peptidoglycan polymers,
thereby preventing the addition of new polymers or crosslinking of existing polymers
(as shown in Figure 1.1)7,17.
Therefore, the arsenal of antibiotics available for Gram-negative bacteria is signif-
icantly smaller than that for Gram-positive bacteria. However, two polypeptide
antibiotics that seem to be effective are colistin and polymyxin B (the latter pro-
duced by Paenibacillus polymyxa and the former by Bacillus colistinus). Both agents
have a similar structure and activity and are generally interchangeable. They have
an electrostatic interaction with the phospholipid bilayer of a Gram-negative bac-
terium’s cell wall which acts as an antagonist for cations, preventing their entry into
the cell18. Cations such as calcium are imperative for metabolism in life, and their
absence essentially “starves” bacterial cells until they die. Their mechanism of ac-
tion is external to the cell therefore bacteria are slow to develop resistance. Despite
the clear advantages of these drugs, they are saved as a last-resort in most clinical
cases because of their relatively high nephrotoxic profile19.
Of course, many different antibiotics exist that have activity against a spectrum of
both Gram-positive and Gram-negative bacteria, with varying degrees of toxicity to
humans. Those listed here are simply examples of the major classes of drugs that
have at least some activity against Gram-positive bacteria (both S. aureus and A.
baumannii are Gram-positive).
1.2.2 Protein Synthesis Inhibitors
Protein-synthesis inhibitors have many different mechanisms of action and some of
these mechanisms are not as well understood as those for cell-wall inhibitors. This
class can be further subdivided into drugs that disrupt the 50S subunit of ribosomal
RNA (rRNA) and those that disrupt the 30S subunit11. Both of these subunits come
together during translation to read messenger RNA (mRNA) and create proteins,
and some drugs work by preventing this from occurring20. Macrolides and linezolids
are examples of 50S-targeting antibiotics, while tetracyclines are the major class of
antibiotics which target the 30S subunit.
It is believed that macrolides operate by inhibiting the addition of new transfer RNA
(tRNA) to rRNA that is actively translating mRNA into proteins21. One possible
target site for these drugs may be peptidyl transferase, which is responsible for cat-
alyzing the reaction between active rRNA and incoming tRNA22. Chloramphenicol
is another antibiotic that has a similar effect by targeting the growing peptide strand
as opposed to the tRNA or rRNA23.
The 50S and 30S inhibitors have the same result as β-lactams and glycopeptides,
however they achieve it through a different route. While 50S inhibitors target pep-
tidyl transferase, 30S inhibitors such as tetracyclines bind to incoming tRNA11. In
effect, they “hide” the tRNA from an active rRNA so that new amino acids cannot
be added to the growing peptide strand.
Protein-synthesis inhibitors are commonly used in conjunction with cell-synthesis
inhibitors in clinical cases. The protein-synthesis component of a multi-drug therapy
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can cause production of malfunctioning and misfolded proteins, some of which may
be cell membrane proteins. These create a disruption of the cell membrane, allowing
cell-synthesis inhibitors into the cell11.
1.2.3 Nucleic Acid Repair and Replication Inhibitors
Antibiotics that inhibit the repair and replication of nucleic acid molecules can be
subcategorized into DNA inhibitors and RNA inhibitors. DNA synthesis inhibitors
include classes of antibiotics such as quinolones and nitroimidazole, while the ma-
jor RNA synthesis inhibitor is rifampin. Rifampin does not belong to a class of
antibiotics (such as quinolones or β-lactams)—rather it is its own class.
Quinolones target DNA gyrase and topoisomerase in bacterial cells, which are re-
sponsible for easing the stress of supercoiling that is caused during replication and
transcription of DNA24. However, not all bacteria use the same DNA gyrases and
topoisomerases, which limits the spectrum of activity for this class of drugs. A
mutation within these enzymes that leaves them able to perform their function can
also give them resistance against antibiotics24.
Nitroimidazoles act as stress agents increasing the presence of reactive oxidative
species within a cell, including host cells of the patient25.
1.3 Staphylococcus aureus
1.3.1 Epidemiology of Staphylococcus aureus Infections
S. aureus is known to cause a multitude of infections in humans, both in the com-
munity and opportunistically in clinical settings. Skin infections, food poisoning,
endocarditis, osteomyelitis, and bacteremia/sepsis have all been documented to be
caused by S. aureus4,26–28. According to the CDC, 30% of the US population car-
ries the bacteria in their noses, though it is harmless most of the time. However,
certain populations are at-risk for opportunistic infections (for example, those with
compromised immune systems)29.
The incidence of multidrug-resistant S. aureus (MRSA) varies based on geography
and demographics, however, it is believed that the origins were in Northern Australia
in the 1980s or 1990s. Even today, prevalence of MRSA in Australia is significantly
higher than that of other countries. In some parts of the country, 42% of the
population carried some variant of MRSA2. Conversely, infections of MRSA remain
relatively rare in Nordic countries such as Norway and Finland. However, it is
thought the reason for this is attributable more to strict surveillance programs rather
than demographics and hygeine30,31.
In the US and Canada, there has been concern that MRSA was being spread through
Prevnar, a pneumococcal vaccination used on children32. This vaccination was
routinely administered beginning in 2000 in US, and 2002 in Canada, and coincided
with a rise in prevalence of MRSA. The use of the vaccine was only recommended in
the US at the time, and the incidence of MRSA increased disproportionally in the
US relative to countries with similar demographics and geography. The timeframe
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in which the increase occurred in tandem with the locale may have pointed towards
some causal link between the two, as researchers have hypothesized (though no such
link has been found to date). With the introduction of the vaccine, prevalence of
Streptococcus pneumoniae has decreased substantially and it is thought that this
species may have created a competitive environment for MRSA. Thus, reducing its
prevalence would allow MRSA to thrive. If there is indeed a link between the two,
the introduction of the vaccination to other European nations beginning in 2006
should mean they would see a similar rise in prevalence of MRSA, which is, in fact,
the case30.
Despite the harmless nature of most S. aureus strains, the increasing prevalence is
problematic for populations across the globe because of the resistance to treatment
options, as well as its ubiquity. When an infection by a resistant strain does arise,
options are severely limited, which can lead to fatalities from infections that were
once considered minor. These sometimes-fatal infections have a relatively robust
dataset to study because of the required hospitalizations. Based on these, there
are some factors on the individual level that can be correlated to the prevalence of
S. aureus. For example, when looking at incidence of bacteremia due to S. aureus,
the highest incidence of bacteremia in developed countries occurs in those older
than 70 or younger than 1 year old31. Males also seem to be approximately 50%
more likely to suffer from bacteremia caused by S. aureus, a phenomenon which
has eluded explanation by researchers. Race also seems to have a strong correlation
with incidence when it comes to bacteremia in the US, though it can be difficult to
separate the effects of social standings and race33. However, when compared globally,
it does seem that Caucasians have a lower incidence than some other populations
(including indigenous Australians, Pacific Islanders, and Africans)31.
1.3.2 Resistance in Staphylococcus aureus
In 1997, Japanese physicians reported the first strain of MRSA that had a reduced
susceptibility to vancomycin, the last-line-of-defense drug for these infections at the
time. The strain was found in an infant who had undergone heart surgery and
developed a fever within two weeks. The physicians isolated the strain from the
site of incision. Because of resistance to vancomycin, the treatment for this patient
became more complex and the treatment period was lengthened34.
Vancomycin has long been the treatment of choice for many Gram-positive bacteria
that develop resistance to β-lactam drugs. With MRSA’s increase in resistance
to vancomycin, medicine is fast approaching a period where infections from these
bacteria will be a death sentence unless other antibiotics are found.
The first strains of S. aureus to display resistance against methicillin preceded
vancomycin-resistant strains by several decades, with the first reports appearing
in 1961. These strains are thought to have obtained their resistance genes via a
bacteriophage. However, these cases were isolated (in the UK) to a few hospitals35.
By the 1970s, there were five known lineages of S. aureus that were known to have
resistance. The reports of these strains increased throughout the following 3 decades,
though they were still sparse in comparison to incidents occurring today36. It should
be noted that the MRSA strains in Australia seem to have developed in isolation,
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although they appeared at approximately the same time (1965)3. It is difficult to
determine the exact mechanisms at play in these Australian cases because it was
limited to fewer than 500 cases per million visits throughout the 1980s and 1990s.
However, there was a clear disproportionality between the Eastern coast of Australia
and the Western coast, where cases were few and far between30.
1.4 Acinetobacter baumannii
1.4.1 Epidemiology of Acinetobacter baumannii Infections
Unlike S. aureus, which has been widely study for decades, Acinetobacter baumannii
has only been gaining popularity with researchers in the last 20 years. It has been
increasingly responsible for outbreaks of bacteremia in hospitals and hospital groups.
However, like S. aureus, this bacterium is ubiquitous—perhaps even more so. A.
baumannii can be found on human skin, in food, soil, and arthropods37. In a study
done by Berlau et. al, 17% of fruits, vegetables, and fungi that were tested grew
a strain of A. baumannii38. The species can be found in almost every level of the
food-chain, it seems. One study found that A. baumannii is by-far the most common
isolate from patients with bacteremia aside from Staphylococcus epidermidis39.
Another study found that 41% of 77 patients who were tested were positive for A.
baumannii in their gastrointestinal tract40. Research indicating its high propensity
for growth on food combined with studies that show similar incidence in hospital
flora could indicate that hospital food is at least partially responsible for the spread37.
More work needs to be done to determine the true incidence of the species in the
environment, as many studies have been done with small sample sizes. However,
empiric research shows that when a hospital environment is created in controlled
scientific conditions, A. baumannii shows significant improvement in survivability.
Some studies have reported an increased lifespan of up to 20 days relative to controls,
while others show evidence that it may be able to survive at lower humidity than
found in its natural reservoirs41,42.
Some studies published in the 1990s provide evidence that the incidence of A. bau-
mannii-caused infections have been on the rise at least since then. One such publi-
cation from 1996 also found that 71% of infections in one hospital were acquired in
the ICU43. It seems as though the phenomenon is not geographically unique, with
another publication reporting a rising incidence in ICU-related infections between
1985 to 1996 in the UK44. A more recent study also found evidence that this was
still the case as recently as 2007 in the UK, as well as in the Netherlands45.
An interesting difference between bacteremia caused by A. baumannii and S. aureus
is that the former doesn’t seem to discriminate between gender groups, as does the
latter. The incidence of bacteremia stemming from A. baumannii between males
and females was roughly equal in some publications39. On the other hand, there
does seem to be a preference for specific age groups, though it seems to almost
oppose age groups preferred by S. aureus. In the same study, the most prevalent
age group that was infected was those approximately 50 years of age39.
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1.4.2 Resistance in Acinetobacter baumannii
The most rudimentary way that A. baumannii seems to protect itself from common
disinfectants is through the formation of a pilus-mediated biofilm46. It has been
shown that these films can be produced on both plastic and glass, which further
provides evidence of the nosocomial nature of most infections caused by the species47.
Other tools that A. baumannii has to increase its survivability include proteins that
allow for iron-acquisition while maintaining serum-resistance in the bloodstream. In
this respect, it is like many Enterobacter species45.
The first major class of antibiotics that A. baumannii was reported to have developed
resistance to is the β-lactams. Similar to many other bacteria, A. baumannii strains
have been found to have genes encoding for several β-lactamases48,49. The strains
exhibiting many of these genes do not seem to be geographically isolated, with
occurrences reported in Turkey, Kuwait, Argentina, Belgium, and France, as well as
the United States50–52. However, there are small variations in the genetic expression
that seem to be more, or less, prevalent based on geography. For example, a study
of resistant strains in New York City showed reduced expression of carbapenem-
resistance genes, but increased expression of class C cephalosporin-resistance genes53.
Variation in expression aside, genes have been found that provide resistance against
all classes of beta-lactams, including carbapenems51,54.
More recently, researchers have also found genes coding for efflux pumps that seem
to give some strains added resistance against carbapenems50. These pumps seem
to also function against other classes of antibiotics, including aminoglycosides and
fluoroquinolones50,55.
S. aureus and A. baumannii also seem to share the Tet(M) protein, which gives them
resistance against tetracyclines. These genes were found to be 100% homologous,
so it is possible that there may have been some form of horizontal transfer in their
lineages56. However, it is important to note that only one report has been published
of this congruency thus far.
Though much less work has been done on the resistance genes found in A.baumannii
in comparison to that done on S. aureus (and other heavily studied bacteria), it
seems we may be running out of time as resistance increases at a faster rate than
we are able to study. This outlines the challenge future physicians will face, as their
arsenal of drugs to combat these infectious agents becomes smaller and smaller. As
with most bacteria, they also seem to have a disproportionate impact on immuno-
compromised patients, in which the array of viable drugs is already limited.
1.5 Small World Initiative
The rate at which resistance seems to be growing is a paramount challenge for
researchers in the coming years. The best course of action, it would seem, would
be to increase the number of man hours dedicated to studying novel antibiotics, as
well as increasing the geographic distribution from which they may be derived. One
solution, namely the Small World Initiative (SWI), was put forth in 2012 at Yale
University.
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The goal of the SWI is to “crowdsource” the search for antibiotics from soil sam-
ples from across the globe57. According to the initiative, two thirds of antibiotics
originated from pathogens found in soil and to increase the efficiency of testing
many soils simultaneously, the initiative proposed a program in which students
around the world could isolate pathogens in their local soil and test for antimi-
crobial activity against ESKAPE pathogens (Enterococcus faecalis, Staphylococcus
aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa,
and Enterobacter species), the most common sources of nosocomial infections.
The SWI released a publication in 2017 that outlined one of the many processes that
could be used to isolate such antibiotic agents. However, teams working towards the
goals of the initiative have chosen to go about the search using various methods based
on criteria such as available materials, local soil attributes, and personal preference.
The commonality for all participants is that their research focuses on the search
for antibiotics in soil. Our research methodology for this publication shares some
similarities with the protocols provided through the SWI, however, a significant
portion of our protocol is proprietary to serve our more specific hypothesis. Though
we have incorporated research methods used in other publications to suit our specific
needs, we share the same over-arching goal as the Small World Initiative in that
we hope to make progress towards discovering novel antibiotics that may already
exist in the environment around us.
Radium Springs, GA was chosen as the site for soil sample collection because of the
trace amounts of radium present in the water table in the area. We hypothesized
that the presence of this radium may create a unique flora that is phenotypically,
and perhaps genotypically, different from soil that could be found elsewhere.
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2 Materials and Methods
2.1 Soil Samples
2.1.1 Collecting Soil
We obtained soil samples from Radium Springs, GA on October 12, 2015, at approx-
imately 9:00 AM. According to the National Centers for Environmental Information,
the temperatures on the day of sample collection ranged from a low of 56° F (13°
C) to 68° F (20° C), and there was no precipitation for at least seven days prior to
collection.
Four samples were collected from various coordinates (longitude and latitude) within
100 meters of the water (Table 2.1). We used a soil probe (AMS 01.40 Plated
Step Probe with Handle purchased from Amazon.com) to obtain plugs of soil that
extended from the surface to approximately 60 cm. These were then divided into
two separate samples: the upper 20 cm were considered surface soil, while anything
below 50 cm was considered as deep soil. Arbitrary names were given to each sample
to allow for easy labelling in later experiments.
Table 2.1: Soil Sample Locations. Samples were collected from two locations at
Radium Springs, GA, at two different depths to account for both aerobic
environments and anaerobic environments.
Sample Lattitude Longitude Depth (cm) Distance from Water (m)
Jurassic Park 1 (J1) 31.525 -84.135 <20 <100 m
Jurassic Park 2 (J2) 31.525 -84.135 >50 <100 m
Zoolander 1 (Z1) 31.524 -84.136 <20 <10 m
Zoolander 2 (Z2) 31.524 -84.136 >50 <10 m
2.1.2 Preparing Soil Sample Stocks
The soil was then prepared for long-term storage by removing any excess moisture.
This was done by placing each sample on a sterile Kimwipe inside of a flow hood
for 24 hours. Another sterile Kimwipe was placed on top of the samples to soak
up excess moisture. Samples were checked for moisture visually and by texture.
Jurassic Park 2 and Zoolander 2 both showed signs of retained moisture after 24
hours, and they were placed into the flow hood for another 24 hours. It was not
necessary to measure the moisture precisely as this step was simply to ensure that
bacterial growth was limited for approximately one week in cold storage while other
preparatory steps were completed.
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Once dry, each sample was bagged separately, labeled and placed into cold storage
at 4° C until needed. Samples were visually inspected daily for condensation to
ensure no excess moisture remained. The storage bags were not opened again until
we were ready to use the soil.
2.2 Tester Strains
Our tester strains were Staphylococcus aureus (ATCC# 12600) and Acinetobacter
baumannii (ATCC# 19606). Both were propagated according to the documentation
from ATCC. After incubation of the initial stock for 24 hours, as advised in ATCC
documentation, glycerol master stocks were made for both strains to preserve genetic
integrity of the original strain before exposure to any experimentation.
2.2.1 Preparing Master (Glycerol) Stock
We prepared our glycerol stock by first streaking each strain on tryptic soy agar
(TSA) and incubating for a period of eight hours at 37° C. This incubation period
was long enough to allow for growth of both strains while limiting it enough so that
individual colonies could be obtained. After incubation, several colonies that were
easily visible but did not overlap with neighboring colonies were selected using a loop.
These were then used to inoculate tryptic soy broth (TSB), which was incubated
at 37° C on a shaker until turbidity was visible (NOTE: each colony was used to
inoculate an individual tube of TSB).
Each tube of TSB was vortexed after incubation to ensure a homogeneous mixture.
From each tube, 500 μL of broth culture were placed into cryogenic vials, along with
500 μL of 50/50 mixture of glycerol and deionized water. The cryogenic vials were
labelled with the date, strain, and a letter designation of A, B, or C. The letter
designation was simply to ensure usage of only one master stock at any given time.
2.2.2 Preparing Working Stock
The remaining tubes of TSB which were used to make the master stock were then
used to make working stock. To do this, we took 100 μL of the broth culture for
each strain and added it to 20 mL of sterile TSB. These were labelled and incubated
for eight hours at 37° C. After incubation, they were moved to cold storage at
4° C until needed. Each working stock was considered viable for a period of two
weeks, at which point it was used to create another batch of working stock. After 3
transfers, we discarded the working stock and created a new batch from the master
stock. These guidelines were put forth by ATCC in their Technical Bulletin No. 6:
Reference Strains.
The eight-hour incubation period was only used in the initial batch of working
stock. After we completed growth curves for each strain, we determined the optimal
incubation periods for each strain to ensure we did not have over- or under-growth.
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2.2.3 Confirming Resistance/Susceptibility of Tester Strains
To confirm we had received the correct strains of both S. aureus and A. bauman-
nii, we used a resistance and susceptibility test and compared our results against
published research. Our S. aureus strain (ATCC# 12600) had been found to show
resistance to 1 μg cloxacillin disks and susceptibility to 10 μg ampicillin disks by an-
other publication58. A prior study also found that A. baumannii (ATCC# 19606)
showed resistance to gentamicin and susceptibility to minocycline, though weight or
concentration were not included in the publication59.
Testing for resistance and susceptibility was done by plating each strain on TSA
with glass beads and placing a single disk of each respective test antibiotic on top.
The plates were then incubated for 12 hours at 37°C, as we were not interested in
limiting overgrowth for this test.
2.2.4 Creating Growth Curves
We completed growth curves for both of our tester strains using sterile TSB as a
control over a period of 18 hours. This was chosen as the upper limit as all inoculates
had reached stationary phase (no change in absorbance for extended period of time).
We used the BioTek Synergy (Winooski, VT, USA) HT microplate reader located at
the Georgia Campus of Philadelphia College of Osteopathic Medicine to automate
the process. The microplate reader was operated by BioTek’s Gen5 imaging software,
version 2.00.18.
We began with our working stock that had been incubated for 8 hours at 37° C,
vortexed, and used to inoculate wells in a 6-well plate. Three wells were used for
our samples in each run of the experiment, as follows:
1. Well 2A contained a control sample with sterile TSB
2. Well 2B contained 1 mL of TSB with 0.2 μL of S. aureus working stock
3. Well 2C contained 1 mL of TSB with 0.2 μL of A. baumannii
Due to laboratory limitations, we shared the remaining three wells in the 6-well plate
with another colleague who was also creating growth curves for another ESKAPE
pathogen (Enterococcus faecalis). Their sample contents are as follows:
1. Well 1A contained 1 mL of sterile TSB
2. Well 1B contained 1 mL of TSB with 0.2 μL of E. faecalis working stock
3. Well 1C was left empty
The addition of all components was done aseptically and each plate was immediately
sealed until ready to be placed in the microplate reader.
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Figure 2.1: Plate Configuration for Microplate Reader. A 6-well plate was
used for the microplate reader. Wells 1A and 1B were used by a colleague
and irrelevant to our experimentation. Well 1C was filled with only
deionized water to ensure proper absorbance readings (should read 0.0
at all times). Well 2A was used as our control, with only sterile TSB.
Wells 2B and 2C were used for our tester strains (S. aureus and A.
baumannii respectively).
Using Gen5 imaging software, we programmed the microplate reader to take a base-
line reading of absorbance at 600 nm and 650 nm in each of the three wells when
the process was started, followed by a reading every hour for the duration of the
experiment (18 hours).
Typically, a wavelength of 600 nm is used to measure optical density of bacteria in
broth60. However, to ensure that we were able to verify our growth curves against
previously published work, it was important to use wavelengths that had been used
in other studies. The only publicly available research using the specific strain of
A. baumannii that we used in our work (ATCC# 19606) measured density at a
wavelength of 650 nm61,62. Therefore, we chose to have this second measurement as
a means of verifying our results against previously published work.
The first run was completed at a temperature of 37° C for 24 hours, followed by a
run at 25° C for 36 hours, and a final run at 43° C for 18 hours–all with the shaker
on 100 RPM. Note that the microplate was discarded after each run had completed,
and a fresh one was made for the next run. This process was then repeated for all
three temperatures with the shaker disabled.
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2.3 Antibiotic Activity of Soil Filtrate Against Tester Strains
2.3.1 Creating Soil Filtrate and Propagating Soil Bacteria
While it was not feasible to determine the total biomass in each sample of soil, it
was important to standardize, even approximately, the number of bacteria we began
with for each experiment. For this reason, 2 grams of soil was used to inoculate every
20 mL of sterile TSB for each step in this process. Alternatively, it would have been
possible to measure the optical density of soil bacteria in broth as we did for our
tester strain growth curves. However, this was not done during experimentation
and would no longer be possible with the original samples, as the flora may have
changed over time.
The soil samples that were placed in cold storage were opened for the first time
to create filtrate for this step. Each of the soil samples was subdivided into three
aliquots with 2.0 grams of soil each using an analytical balance accurate to tenths
of a milligram. The aliquots of each soil sample were immersed into 20 mL of sterile
TSB. The inoculation of TSB was done in 50 mL conical tubes which were vortexed,
allowed to settle for 30 minutes, and vortexed again. Each tube was then filtered
using mesh filters with a pore size of 100 μm to remove soil particulate, leaving all
microbes smaller than 100 μm in solution. Each broth culture was then incubated
on a shaker at 25° C, 37° C, or 43° C (one inoculate per temperature). The 25°
C samples were incubated for 16 hours, the 37° C samples for 8 hours, and the
43° C samples for 8 hours. These values are based on optimal growth periods and
temperatures for our tester strains, and will be referred to as our standard incubation
period. There was no reason to favor incubation for the same time periods that were
optimal for tester strains for the soil bacteria—future experiments should consider
other time-frames.
After incubation, we immediately moved all samples to cold storage at 4° C until they
were needed. These samples were kept as working stock of soil bacteria for 2 weeks,
at which point they were used to create new working stock following the procedure
described above (Preparing Working Stock). The working stock was propagated into
indefinite generations (as opposed to working stock of our tester strains, where we
discarded each working stock after 3 generations of propagation).
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Figure 2.2: Creating Soil Working Stock. Four soil samples were obtained from
Radium Springs, GA. From each sample, three aliquots of two grams
each were made. Each aliquot was used to inoculate a sterile conical tube
with 20 mL of TSB. The mixture was properly vortexed and filtered with
a pore size of 100 µm, removing all visible soil particulates. Of the three
aliquots from a given soil sample, one was placed in 25° C incubation,
one in 37° C, and the last in 43° C incubation. After incubation, these
tubes were stored. These were considered our “soil working stock”.
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2.3.2 Testing Filtrate for Antibiotic Activity
Our goal for this experiment was to test the metabolites produced by soil bacteria
as possible antibiotic agents against the tester strains S. aureus and A. baumannii
We began with working stock created from each of the four soil samples, which had
been kept in storage until this step was to be completed. From each of the soil
sample stocks, we obtained 1 mL of TSB after vortexing. This was passed through
a 0.22 μm syringe filter to remove all microbes, leaving only metabolites which were
able to pass through the pores.
Four sterile antibiotic sensitivity disks were then soaked in each of the filtered so-
lutions and placed on a sterile Kimwipe in a flow hood to dry. As the disks dried,
we plated our tester strains, S. aureus and A. baumannii on TSA using glass beads
(Fisher Scientific #MP15000550) to ensure an even growth, creating a “lawn”. We
used 60 mm plates with 10 μL of tester strain TSB. These were incubated for 15
minutes at 37° C to allow tester strains to adhere to the TSA.
Finally, both disks soaked in filtrate from a given soil working stock were placed
on top of the plated tester strains. The plates were then incubated for standard
incubation periods1.
Figure 2.3: Antibiotic Activity in Soil Working Stock Filtrate. A 0.22 µm
syringe filter was used to remove all the bacteria from soil working stock,
leaving only media and metabolites. Each sample of soil working stock
yielded 12 antibiotic disks (half for testing against A. baumannii and
half for S. aureus). We used two disks per plate of tester strain, yielding
three plates of each tester strain per soil working stock. These were used
for our three standard incubation configurations.
1Standard incubation criteria: 25° C for 16 hours, 37° C for 8 hours, or 43° C for 8 hours.
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2.3.3 Co-culturing Soil Bacteria with Tester Strains using Dialysis
Tubing
Co-culturing multiple bacteria can induce expression of metabolites in one species
that act as antibiotic agents towards one or more of the remaining species. We
adapted our co-culturing method from Marmann63.
For this step, we obtained Biotech CE Dialysis Tubing (Spectrum Labs #131456)
with a 300 kDa molecular weight cut-off (MWCO). It was cut into strips approxi-
mately 10 cm in length and clipped on end with a 16 mm SnakeSkin Dialysis Clip
(ThermoFisher #68011). This allowed us to fill the tubing with 10 mL of working
stock from each of our soil samples using a pipet controller. Another clip was then
used to seal the opposite end of the tubing.
A 50 mL conical tube was filled with 20 mL of sterile TSB, which was inoculated
using 0.2 uL of S. aureus working stock per 1 mL of TSB (4 uL total). Filled and
sealed dialysis tubes were then transferred into the S. aureus TSB solution. This
was carried out for each of the four soil samples in a separate conical tube, and
repeated three times to achieve our standard incubation periods.
2.3.4 Testing Co-cultured Filtrate for Antibiotic Activity
After incubation, the tester strain from co-cultures was discarded and working stock
from soil samples was removed from the dialysis tubing. We modified the procedure
described in “Testing Filtrate for Antibiotic Activity” for the remainder of the ex-
periment.
We removed the soil working stock from the dialysis tubing and filtered it into three
separate samples: one sample was made by filtering with a 0.65 μm syringe filter,
another with a 0.45 μm syringe filter, and the last with a 0.22 μm syringe filter.
Note that the result of this step is the creation of three separate filtrates (each using
a different pore size filter) rather than filtering the sample with each pore size in
succession (Figure 2.4).
Four sterile antibiotic susceptibility disks were soaked in each filtrate and dried. We
also made plates with 10 μL of S. aureus working stock on TSA using glass beads
to create a lawn. These were incubated for 15 minutes so our tester strain could
adhere to the TSA while the antibiotic disks were dried in a sterile environment to
remove excess TSB. The dried disks were placed onto the S. aureus plates (two disks
from each of the filtrates were placed on one S. aureus plate). The final step was to
complete a standard incubation.
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Figure 2.4: Co-culturing Methodology. Dialysis tubing was filled with soil work-
ing stock. The tubing allowed passage of media and metabolites smaller
than 300 kDA, but created a physical barrier for bacteria. This test was
done to see if the stress of our tester strains would cause our soil bac-
teria to create different metabolites than if they were to be incubated
independently.
2.4 Antibiotic Activity of Soil Precipitate Against Tester
Strains
2.4.1 Obtaining and Stamping Precipitate
For this technique, a Buchner funnel was used in association with a vacuum pump
and filters with various pore sizes. The goal was to remove metabolites and media
from our soil working stock, leaving behind only bacteria. These bacteria were then
plated directly on top of lawns of S. aureus. It should be noted that A. baumannii
was not used from this point forward due to exponential growth in samples after
each consecutive step. Each of the four soil samples was filtered using filter paper
with three different pore sizes. Each of these filtrates was then tested in a co-culture
against the tester strains at three different temperatures. Therefore a total of 108
plates per tester strain per repitition of this test would be needed. For the same
reason, we also chose not to pursue testing at 43° C from this point forward to limit
the number of samples further. This was done to reduce costs of sequencing multiple
samples.
The configuration of the vacuum system can be seen in Figure 2.5. The vacuum
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system was used to speed up the separation of media from the bacteria, which was
to be plated with our tester strain.
Figure 2.5: Vacuum Pump with Buchner Funnel. A Buchner flask was used to
speed up the separating of media and metabolites from bacteria. Filters
with various pore sizes were placed inside the funnel and soil working
stock was poured in with the vacuum pump running. This pulled the
solution through the filters, while the bacteria were caught.
Working stock from each of the four soil samples was run through a 0.65 μm filter
first, followed by a 0.45 μm filter, and finally a 0.22 μm filter. Therefore, each of our
soil samples rendered three filters with bacteria to be plated on S. aureus. These
filters were to be used for incubation at 25° C, however, this process was repeated to
create filters that could be used for incubation at 37° C. At completion of filtering,
each soil sample yielded six filters to be plated (the total number of filters was 24,
six from each of four samples)(Figure 2.6).
Note that each soil sample was filtered in filter paper of decreasing pore size (0.65μm,
followed by 0.45 μm, followed by 0.22 μm). This was done to ensure that the largest
bacterial cells were retained on the largest pore size, while allowing the smaller cells
to pass through to the next pore size.
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Figure 2.6: Plating Precipitate from Soil Working Stock. All four soil working
stocks were filtered using a Buchner flask. The largest pore size was used
first (0.65 µm), followed by 0.45 µm, and finally 0.22 µm.
2.4.2 Culturing Precipitate atop Tester Strains
The filters produced from the precipitate (as shown in Figure 2.6) were marked with
a small tick mark at an arbitrary location. Each filter was then stamped, or replica
plated, onto sterile TSA and a corresponding tick mark was made on the plate,
corresponding with the identical tick on the filter. The same filter was then replica
plated onto a plate that had been prepared with 10 μL of S. aureus working stock.
Again, a tick mark was made on the plate corresponding to the identical tick on
the filter. This was done so that we could align the plate with only precipitate with
the plate of S. aureus AND precipitate. If a zone of inhibition was seen around a
given colony on the plate with our tester strain, we could then isolate the identical
colony from our precipitate plate and ensure we were getting only the unknown soil
bacteria rather than a mixture of soil bacteria and S. aureus.
Each soil working stock yielded six filters: two 0.65 μm filters, two 0.45 μm filters,
and two 0.22 μm filters. Each filter then yielded two plates: one for 25° C and one
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for 37° C. Since each soil working stock yielded a total of 12 plates, we had 48 plates
at the end of this step (12 plates times 4 soil samples). A hierarchy chart starting
with one soil sample is shown below (Figure 2.7).
Figure 2.7: Hierarchy of Stamping Process. Only one soil sample is shown.
This hierarchy would be identical for each soil sample.
If we had continued with A. baumannii and our 43° C experimentation, we would
be left with 144 plates at this point, and this would multiply as the experimentation
continues. For this reason, we limited our samples.
2.4.3 Selecting and Propagating Colonies with Possible Antibiotic
Activity
After incubation of all the plates, we checked for zones of inhibition around the
colonies of unknown bacteria that had grown on the plate with our tester strain. If
a zone of inhibition was visible, we circled the location of the colony on the underside
of the TSA plate. After all plates with both soil bacteria and tester strain had been
inspected, we placed the plates with no visible zones of inhibition in cold storage at
4° C.
For the remaining plates (those with visible zones of inhibition), our goal was to
isolate the unknown bacterial species for further testing. To do this, we first aligned
the two plates that were from the same stamp using their corresponding tick marks
(e.g. the co-cultured plate created with a 0.22 μm filter from Jurassic Park 2, in-
cubated at 25° C was placed on top of the plate with only soil bacteria that was
created with the same filter). The circles on the underside of the co-culture plates
indicating zones of inhibition were traced over to the plates with only soil bacteria.
In this way, we were able to keep track of which colonies we had isolated in the
following steps.
After all prospective unknowns had been marked on the soil-bacteria-only plates,
we used the aseptic technique with a loop to pick off individual colonies and used
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them to inoculate sterile TSB (each unknown colony was used to inoculate its own
tube of TSB). The TSB was then incubated at 37° C until turbidity was visible. It
was not imperative to be more exact than “visible” at this stage because we were
simply trying to grow the unknown in isolation so it could be used to streak a plate
of sterile TSA. Using the loop technique, we streaked sterile TSA with each of the
unknown broth cultures (again, each unknown was used to inoculate its own plate
of TSA).
The last step for isolation was to select a single colony from each of the streaked
plates and inoculate sterile TSB. These would be our working stock for each of the
unknowns. The first batch of working stock was also used to create a master stock
based on the procedure outlined in Preparing Master (Glycerol) Stock.
In summary, we selected colonies from the replica plates using a loop and aseptic
technique and incubated them in TSB. These broth cultures were then used to
create streak plates on sterile TSA to give us another opportunity to select an
isolated colony with a loop. Finally, a loop was used to select a colony, which was
used to inoculate another tube of TSB. This second broth culture was used to create
stock (Figure 2.8).
Working stock of our unknowns was considered viable for two weeks, at which point
it was used to create a new batch. After 3 generations, the working stock was
discarded and new stock was created from the master stock.
Figure 2.8: Selecting Isolates for Further Testing. Isolates were selected if
a zone of inhibition was visible. The loop technique was used on the
plates with only our soil precipitate, NOT the plates with our tester
strain. This was to ensure that we obtained a pure sample of unknown
bacteria that was able to inhibit growth of S. aureus.
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2.5 Identifying Bacteria from Samples Exhibiting Antibiotic
Activity
2.5.1 DNA Sequencing
DNA sequencing was outsourced to EMSL Analytical Incorporated (EMSL Test
Code M192). The samples were sent to their laboratory located at: 200 RT 130,
Cinnaminson, NJ 08077. Because of the prohibitive cost of high throughput se-
quencing, we were not able to have all samples sequenced. We were limited to only
one of the unknown samples, and we chose sample Z2 0.22 25 A (each sample is
discussed further in Results and can be found in Table 3.2). This unknown with
antibiotic activity against S. aureus was found less than 10 m from water’s edge at
Radium Springs, GA, at a depth of greater than 50 cm from surface (Table 2.1).
This sample was chosen because it was one of four isolates that produced an antibi-
otic activity against S. aureus from a single soil sample, using a single filter size
(0.22 μm), at a single incubation temperature (25° C). We believed that this showed
the greatest potential for further research, and our limitation of sequencing only one
sample meant we were forced to choose the sample with most potential.
EMSL required that our samples be used to inoculate TSA slants and sent overnight
to their lab to ensure cells were still viable on their arrival. They used 16S ribosomal
RNA sequencing to determine the genus and species of our sample. The sequences
they found were cross referenced with the GenBank database from the National
center for Biotechnology Information (NCBI). The sequencing results from EMSL
can be found in the Appendix (DNA Sequencing Results).
2.5.2 Gram Stain, Mannitol Fermentation, Motility, and Crystal
Formation Testing
All samples with possible antibiotic activity against S. aureus were first Gram-
stained using the protocol described in the Appendix (Gram Stain Protocol). Gram-
stains were completed using working stock that was created in an earlier stage
(Selecting and Propagating Colonies with Possible Antibiotic Activity). Based on
the result of the Gram stain, one of two dichotomous keys (one for Gram positive
species, and one for Gram negative species) would be used to carry out further iden-
tification tests; however because all of our samples were found to be Gram positive,
only the Gram positive dichotomous key is included here (Figure 2.9)64.
Gram stains were also used to determine spore formation, the second step of the
dichotomous key when samples were seen to be bacillus. Spore formation was then
confirmed using malachite green and safranin staining. Because spores were present
in all our samples, we did not complete a catalase test. We then used a mannitol
fermentation test to narrow down possibilities. This allowed us to determine that
all our samples were species in “Group 1” bacilli.
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Figure 2.9: Identification Dichotomous Key. This key was followed for identifi-
cation of our unknown samples, narrowing down the possible outcomes at
each step. Key was obtained from prior publication by Amanda Nguyen.
A secondary dichotomous key was required to narrow down which species our un-
knowns may be, as this dichotomous key for all Gram positive bacteria did not
differentiate between species within Group 1 Bacilli. This secondary key (Figure
2.10) for differentiating between Group 1 Bacilli was designed by Amanda Nguyen,
a fellow student, based on guidelines put forth by Public Health England in UK
Standards for Microbiology Investigations64,65.
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Figure 2.10: Dichotomous Key for Group 1 Bacillus. This key allowed fur-
ther differentiation of our unknown strains. Obtained from Amanda
Nguyen based on information from UK standards for Microbiology In-
vestigations.
We then conducted penicillin susceptibility tests on all our samples and found all
unknowns to be resistant. The next step in the above key was to carry out motility
testing, for which we used pre-made motility, indole, and ornithine (MIO) tubes
which also tested for indole production and ornithine decarboxylase, though these
tests were unnecessary based on previous identification tests. Finally, some samples




3.1.1 Confirmation of Resistance and Susceptibility of Tester Strains
We are confident that ATCC delivered the correct strains of bacteria to us, so this
step was simply an authentication test before moving further into experimentation.
A previously published study used ATCC# 12600 (S. aureus) for resistance and
susceptibility testing and our results were congruent with their research55. In both
cases, the strain of S. aureus was found to exhibit resistance to cloxacillin and
susceptibility to ampicillin. Another team conducted similar research on our strain
of A. baumannii (ATCC# 19606), and our results for this strain were congruent to
theirs: A. baumannii (ATCC# 19606) was found to be resistant to gentamicin and
susceptible to minocycline (Table 3.1)59. It was not considered necessary to further
authenticate that we had received the correct strains from ATCC.
Table 3.1: Susceptibility Testing. Results for susceptibility testing are shown here.
The concentration of antibiotics was selected based on the studies refer-
enced above.
Tester Strain Antibiotic Disks Resistance Zone of Inhibition
Staphylococcus aureus (ATCC# 12600) Cloxacillin (1 Î¼g) Resistant 14 mm
Staphylococcus aureus (ATCC# 12600) Ampicillin (2 Î¼g) Susceptible 23 mm
Acinetobacter baumannii (ATCC# 19606) Gentamicin (10 Î¼g) Resistant 13 mm
Acinetobacter baumannii (ATCC# 19606) Minocycline (30 Î¼g) Susceptible 8 mm
3.1.2 Growth Curves
Growth curves were completed two times at each temperature (25° C, 37° C, 43°
C) with the shaker on, and two times at each temperature with the shaker off,
for a total of 12 runs. During each run, absorbance readings were taken at two
wavelengths (600 nm and 650 nm). Noise introduced by TSB was removed by
subtracting the absorbance of the sterile TSB at the matching wavelength and time
from each reading. For example, in the first run at 37° C with the shaker on, the
absorbance of S. aureus after eight hours at 600 nm was 0.692 (OD), while the
absorbance of sterile TSB was -0.006 (OD). To normalize the value of the S. aureus
reading, we subtracted -0.006 (OD) from 0.692 (OD), giving us an absorbance of
0.698. Note that a negative absorbance is not possible, however, the magnitude of
the reading here is negligible. These curves were completed several times to ensure
repeatability and yielded some anomalous negative readings in the first hour each
time.
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The normalized values for the two corresponding readings were averaged together.
For example, the normalized absorbance of S. aureus during the first 37° C run with
shaking after eight hours was 0.698 (OD). During the second run with the same
settings, the normalized absorbance after eight hours was 0.712 (OD). These values
were averaged, giving a final value of 0.705 (OD). This was done for each reading in
each run.
The normalized and averaged values for each temperature, with and without the
shaker, were consolidated into one table for S. aureus, and one for A. baumannii.
Both of these tables can be found in the Appendix (Staphylococcus aureus Growth
Data* and Acinetobacter baumannii Growth Data). For S. aureus, the readings taken
at 600 nm were used, while the readings at 650 nm were used for A. baumannii The
values in both tables were then charted using Microsoft Excel 2017 to obtain a
final growth curve (Figure 3.1 and Figure 3.2). These values were plotted using
absorbances at a wavelength of 600 nm. A consolidated table was also created for
A. baumannii using the same process, although the readings used were taken at a
wavelength of 650 nm.
Figure 3.1: Growth Curves for S. aureus. Data can be found in Appendix A.2.
Optimal incubation periods (“standard incubation”) for S. aureus were
obtained from this chart.
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Figure 3.2: Growth Curves for A. baumannii. Data can be found in Appendix
A.3. Optimal incubation periods (“standard incubation”) for A. bau-
mannii were obtained from this chart.
3.2 Antibiotic Viability of Soil Filtrate
3.2.1 Antibiotic Activity of Soil Filtrate Against Tester Strains
We tested filtrate for antibiotic activity a total of three times (beginning with the
original soil working stock each time). Only two sets of disks showed any zones
of inhibition when placed on our tester strain. In fact, some of the metabolites
from various samples seemed to encourage growth for our tester strains. The two
sets of disks that showed inhibition happened to be our control disks, soaked only
in sterile broth (Figure 3.3). The remaining disks showed no inhibition of tester
strains (Figure 3.4).
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Figure 3.3: Zones of Inhibition from Control Samples. Left, disks soaked in
sterile TSB placed on A. baumannii and incubated at 25° C. Right, disks
soaked in sterile TSB placed on S. aureus and incubated at 37° C.
The disks from Zoolander 2 filtrate and Jurassic Park 2 filtrate, particularly when
incubated with the tester strains at 25° C and 37° C seemed to encourage the growth
of our tester strains in their vicinity. Zones of higher density growth were clearly be
seen in these plates.
This step was repeated a total of three times, however only one set of results is shown.
Results from the second and third repetition showed no significant differences.
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Figure 3.4: Antibiotic Activity of Soil Working Stock Filtrates. Rows: A) A.
baumannii incubated at 25° C, B) A. baumannii incubated at 37° C, C)
A. baumannii incubated at 43° C, D) S. aureus incubated at 25° C, E) S.
aureus incubated at 37° C, F) S. aureus incubated at 43° C. Columns:
Disks soaked in 1) Sterile broth, 2) Zoolander 1 filtrate, 3) Zoolander 2
filtrate, 4) Jurassic Park 1 filtrate, 5) Jurassic Park 2 filtrate.
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3.2.2 Antibiotic Activity of Co-Cultured Soil Filtrate Against Tester
Strains
Co-culturing the soil working stock with working stock of our tester strains did not
yield significantly different results than culturing them independently. The results
were largely similar to those from the previous section. Only a selected sample is
shown here, as the number of samples increased dramatically in this step (Figure
3.5).
Unlike filtrate from independently cultured soil working stock, filtrate from co-
cultured soil working stock did not seem to encourage growth of our tester strains.
Figure 3.5: Antibiotic Activity of Co-cultured Filtrate. Plates from all sam-
ples in three repetitions of this step yielded similar plates to those shown
here. Disks in this sample were soaked in filtrate from Jurassic Park 1
working stock that had been co-cultured with S. aureus. Soil working
stock was filtered using .45 µm syringe filters before placing on our tester
strain.
3.3 Antibiotic Viability of Soil Precipitate
3.3.1 Antibiotic Activity of Soil Precipitate Against Tester Strains
When our soil bacteria were stamped onto S. aureus and incubated, a total of 13
unknown colonies were found with zones of inhibition around them. The zones
of inhibition are not visible in the photographs below, however they are clear and
distinct when looking at the plates directly (Figure 3.7).
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Figure 3.6: Samples with Zones of Inhibition Visible. Each soil sample that
yielded any inhibition is shown in the top row (Jurassic Park 1, Jurassic
Park 2, and Zoolander 2). Next, the filter size that yielded the inhibitive
sample is shown (in µm). Next, the incubation temperature used to
arrive at the inhibitive sample is shown. In the grey rectangles, each
sample is given an identifying name for convenience.
Figure 3.7: Soil Precipitate Stamps on S. aureus. The plates shown here were
the ones incubated at 37° C with the soil bacteria on top of the tester
strain. The soil bacteria on sterile TSA is not shown. Zones of inhibition
are present but not visible on photographs.
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3.3.2 Propagation of Colonies with Indications of Antibiotic Activities
The colonies selected as possible antibiotic emitters (as indicated in Figure 3.6) were
propagated in sterile TSB. The plates are also shown in Figure 3.7, however zones
of inhibition are not visible in the photographs.
From the broth cultures, the unknown bacteria were streaked onto individual plates
and incubated again. Finally, a single colony was chosen to create working stock and
master stock. This was done to create as pure a culture (monoclonal) as possible
with the available tools. The labels for each of the colonies selected as progenitors
for the stocks are shown below (Table 3.2).
In Figure 3.8, we included images of the colonies that were selected to create working
and master stock. The selected colonies were isolated (there was no contact with
neighboring colonies) and regular in shape. Only one colony was picked off with
a loop to be used to inoculate sterile TSB. Our master stock, stored at -80° C, is
composed of progeny from these colonies and should be identical as the cells were
not passaged again after isolates were obtained from the streaks below.
Figure 3.8: Selected Progenitor Colonies for Potential Antibiotic-
producing Bacteria. Streak plates created using unknown bacteria
from soil samples, as described in “Propagation of Colonies with Indi-
cations of Antibiotic Activities”. Colonies that were selected to create
stocks are circled here.
The zones of inhibition created by each of the selected isolates on S. aureus were
all approximately 2 mm in diameter, however they were too small to effectively
measure.
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Table 3.2: Selected Progenitor Colonies for Potential Antibiotic-producing Bacteria
(Labels).
1 2 3 4 5
A) J1 0.22 25 A J1 0.22 25 B J1 0.22 25 C J1 0.45 25 A J1 0.65 25 A
B) J1 0.65 37 A J2 0.65 37 A Z2 0.22 25 A Z2 0.22 25 B Z2 0.22 25 C
C) Z2 0.22 25 D Z2 0.22 37 A Z2 0.22 37 B
3.4 Identification of Select Samples with Possible Antibiotic
Activity
3.4.1 DNA Sequencing
The complete results from EMSL DNA sequencing (EMSL Test Code M192) can be
found in the Appendix (DNA Sequencing Results). As expected based on our results
from manual identification using dichotomous keys, DNA sequencing indicated that
our unknown bacteria belonged to Group 1 bacilli. EMSL was able to narrow down
the sample to one of three species: Bacillus thuringiensis, Bacillus cereus, and
Bacillus mycoides. However, because of the homogeneity between the genomes of
these bacteria they were unable to further differentiate.
EMSL’s report states that identification of bacterial samples is done by sequencing
the DNA coding for 16S ribosomal RNA (rRNA) and comparing with GenBank
database at the National Center for Biotechnology Information (NCBI). Therefore,
we can conclude based on their results that all three of the species they listed
(B. thuringiensis, B. cereus, and B. mycoides) have a conserved 16S rRNA that is
identical to one another.
The sample that was chosen to be sequenced (Z2 0.22 25 A) was also identified man-
ually via the dichotomous keys as described in Gram Stain, Mannitol Fermentation,
Motility, and Crystal Formation Testing in the Appendix. Manual identification re-
sults indicated that the species in question was B. mycoides, thus confirming EMSL’s
sequencing results.
3.4.2 Identification Tests and Dichotomous Key
The identification tests using the dichotomous key were conducted on all samples
that produced a zone of inhibition against S. aureus (Figure 3.6). However, only
selected results are shown for each step in the identification process. Protocols for
each of the identification tests can be found in the Appendix (Identification Tests).
Pictures of Gram stains of our unknown bacterium from the soil samples are shown
in Figure 3.9. All samples (including the ones not shown here) were Gram positive,
and therefore appear purple under stain. We are also able to determine that all
samples are bacilli (rod-shaped).
We were further able to confirm that samples were Gram positive by using Mac-
Conkey agar and PEA. MacConkey agar is selective for only Gram negative species
and we saw no growth. PEA, conversely, inhibits growth of Gram negative species,
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thus selecting for only Gram positive species. It is typically used to identify Staphy-
lococcus species, but has also been shown to grow Bacillus species66.
We then used malachite green staining as described in the Appendix (Spore For-
mation (and Malachite Staining) Protocol) to determine whether our samples were
spore-forming bacteria. We found that all of our samples were spore-formers. Fi-
nally, we conducted motility testing in TSA filled test tubes using the procedure
described in the Appendix. The results from the motility tests were confirmed by
using MIO tubes which also tested for indole and ornithine testing (Figure 3.10).
We also tested each of the samples for susceptibility against penicillin to confirm
that we did not have Bacillus anthracis in any of our samples. This was the only
differentiating trait between B. anthracis and the other species in Group 1 Bacillus.
Susceptibility tests were completed following the procedure described in Confirming
Resistance/Susceptibility of Tester Strains.
The results for each of these tests are displayed in Table 3.3. Using this table along
with the dichotomous keys (Figure 2.9 and Figure 2.10) above, we were able to
determine the composition of each of our samples to the species level.
Table 3.3: Compiled Identification Tests.
Sample Gram PEA McC Spore Cat. Oxi. Man. Susc. Mot. Orn. Likely Strain
J1 0.22 25 A + + - + + - - S + + Bacillus anthracis
J1 0.22 25 B + + - + + - - S - - Bacillus anthracis
J1 0.22 25 C + + - + + - - S + - Baccilus cereus
J1 0.45 25 A + + - + + - - R - - Bacillus mycoides
J1 0.65 25 A + + - + + - - R - + Bacillus mycoides
J1 0.65 37 A + + - + + - - R - + Bacillus mycoides
J2 0.65 37 A + + - + + - - R - + Bacillus mycoides
Z2 0.22 25 A + + - + + - - R - + Bacillus mycoides
Z2 0.22 25 B + + - + + - - R - + Bacillus mycoides
Z2 0.22 25 C + + - + + - - S + - Bacillus anthracis
Z2 0.22 25 D + + - + + - - R + + Baccilus cereus
Z2 0.22 37 A + + - + + - - R + + Bacillus cereus
Z2 0.22 37 B + + - + + - - S - - Bacillus anthracis
Z2 0.22 37 C + + - + + - - S + + Bacillus anthracis
Z2 0.22 37 D + + - + + - - S + - Bacillus anthracis
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Figure 3.9: Selected Gram Stains. All strains were Gram stained and found to
be Gram positive.






Growth curves were done for both tester strains to ensure that we did not allow them
to overgrow in future experiments, and as a baseline against soil bacteria. While it is
unlikely that soil bacteria would exhibit a similar growth curve, there is no feasible
method to determine the ideal growth period for a sample with countless distinct
species in it. It was also not possible to test many different incubation periods
because the number of samples grows exponentially with each consecutive step of
this research. Each additional incubation period would necessitate four additional
filtrates in Creating Soil Filtrate and Propagating Soil Bacteria and Co-culturing
Soil Bacteria with Tester Strains using Dialysis Tubing. In the following portions
of the experiment, this number would further multiply.
The optimal incubation period for our tester strains was the time it took for them
to reach the center of their “exponential” or “log” phase, labelled in Figure 4.1.
Figure 4.1: A typical growth curve for a bacterial species. The Y-axis shows
units of growth (either CFU or absorbance) on a logarithmic scale, while
the X-axis is time.
This template was used to determine an “optimal” incubation period for our tester
strain, which was also used as the incubation period for our soil samples. However,
it is likely that the soil samples incubated in different conditions or for different
lengths of time may have rendered different results in further steps. This is a
possible alteration of our research for academics who may choose to continue this
research.
Figure 3.1 and Figure 3.2 show the growth curves of both tester strains. While both
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strains thrived at 37° C with a shaker, some clear differences can be seen. Perhaps
the most clear difference is the incubation period at 25° C with a shaker. In this
configuration, S. aureus growth severely lags in relation to A. baumannii.
In the S. aureus growth curve, a spike in absorbance can be seen 13 hours after the
beginning of the incubation period. Of the two identical runs that were done to get
these data points, one showed a large deviation from the norm for this time point,
while the other was normal. This indicates that it was an abnormal reading. Because
the growth curve quickly resumed its normal course after hour 13, we believe there
was no contamination in the samples, which would have altered the remainder of
the curve.
One final thing to note for these growth curves is the small negative value for ab-
sorbance after 1 hour of shaking at 43° C. The only way a negative value would be
attained is if our control had a larger absorbance than our sample. This could occur
if the control had been contaminated and exhibited growth of biomass, however,
this is unlikely as the absorbance of our control sample did not change throughout
the incubation period. This leads us to believe that there was an error in creating
the nutrient broth. A slightly higher volume of nutrient broth in relation to distilled
water during preparation of the broth could have created TSB that absorbs more
light. If the broth used in the control sample and the bacterial samples were of
different origins, it is possible that this artifact is insignificant.
4.2 Antibiotic Activity in Soil Filtrate
As stated in the results, there was no visible zone of inhibition around any of the disks
soaked in soil working stock filtrate, regardless of whether they were co-cultured with
tester strain working stock or independently. The two plates that exhibited what
looks like a zone of inhibition in Figure 3.3 were both control plates. The disks in
these plates were soaked only in sterile TSB.
The probable cause of this “zone of inhibition” is simply incomplete drying of the
disks. They may have retained TSB, and when placed on our tester strain, expelled
some onto the plate. This expulsion of TSB may have carried with it, the nearby
tester strain.
Perhaps more interesting than the lack of any zones of inhibition was the consistency
with which filtrate from Jurassic Park 2 and Zoolander 2 samples encouraged the
growth of our tester strains at both 25° C and 37° C. This experiment was done three
times, and each cycle yielded a similar result with respect to these two samples. It is
likely that the bacteria from these samples produce metabolites that are beneficial
to the growth of both S. aureus and A. baumannii
Interestingly, both samples that encouraged growth of our tester strains were ob-
tained from relatively anaerobic environments (>50 cm from surface soil) as shown
in Table 2.1. This result also provides a stark difference from research done by Ki
Chi and Jarvis Li, who found that deep-soil bacteria commonly release phenylacetic
acid, a compound that acts as an antibiotic agent against both A. baumannii and S.
aureus67. Other publications have also found that this compound increases immune
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system activity against A. baumannii in mammals68.
While the results for this test were underwhelming in terms of antibiotic activity,
we believe the process by which we did the experimentation was novel—another
publication could not be found that had a similar methodology. However, it may be
advisable for researchers to modify the methodology slightly. Rather than carrying
out a “shotgun” approach and testing a concoction of unknown soil bacteria for
antibiotic agents, it would seem to be more efficient to look at commercially available
antibiotics and work backwards to see what kinds of strains are most likely to
produce similar molecules. For example, if it were determined that Gram-negative
bacteria are more likely to produce a given molecule that may exhibit antibiotic
activity, one could kill Gram-positive bacteria in a sample using pure singlet oxygen,
an excited form of molecular oxygen69. With only Gram-negative bacteria in a
sample, metabolites produced may be significantly different.
4.3 Antibiotic Activity in Soil Precipitate
As shown in Figure 2.4, each filter was stamped onto a plate that had been prepared
with 10 μL of S. aureus working stock (using glass beads to spread uniformly). The
goal of this exercise was to transfer the bacteria that had been retained by each filter
to TSA with our tester strain. If a specific strain of bacteria is producing metabolites
that are detrimental to the growth of S. aureus, it would be more likely to show a
zone of inhibition on a plate immediately surrounding the unknown bacteria than it
would in filtrate that was composed of metabolites from all the bacteria in our soil
samples. It would also be possible to isolate the bacteria of interest that produced
this antibiotic agent, as it would be visibly separated from other species on a plate.
A total of 13 strains of unknown soil bacteria produced inhibitory effects on S. aureus.
Of the 13 strains, nine were found in a filter pore size of 0.22 μm, which implies that
the individual cells of these bacteria were smaller in size than 0.45 μm but larger
than 0.22 μm. Of the 13 strains, nine were also found in media incubated at 25° C,
which may indicate that species that can inhibit S. aureus growth tend to thrive
at room temperature more than body temperature. However, it may be that body
temperature allows other species to thrive and out-compete the unknowns that have
inhibitory effect. Regardless of the cause, future researchers may want to focus their
efforts on a 25° C growth temperature.
One interesting finding of our research was that for samples collected near the water
(<10 m), the deeper soil yielded more species with antibiotic activity against our
tester bacteria. However, for soil that was collected further away from the water
(<100 m), the surface soil was more likely to yield antibiotic activity against the
tester strain. The soil collected from less than 10 m from the water also only
exhibited antibiotic activity from species whose cells were smaller than 0.45 μm,
whereas the soil that was collected from a larger distance exhibited antibiotic activity,
in some cases, where the bacterial species were larger than 0.65 μm. This is another
procedure in which future research may be able to target bacteria more precisely.
For example, if working with soil near the water at Radium Springs, GA, one would
focus on bacterial species whose cells are generally smaller than 0.45 μm. The further
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the soil samples are collected, the larger the spectrum of size that may be of interest.
4.4 Prospective Species with Antibiotic Activity
After isolation of our possible candidates that may have antibiotic activity against
the tester strain S. aureus, we needed to identify our samples. We approached this
from two directions—we sent a sample to another lab to have it sequenced and
compared against the NCBI database, and we used a dichotomous key to run iden-
tification tests and narrow down the possibilities with each consecutive experiment.
We found that all our possible candidates were Gram positive, exhibited spore for-
mation, produced catalase, lacked oxidase, and could not ferment mannitol. This
led us to believe that all our samples were species from Bacillus Group 1 (Bacillus
anthracis, Bacillus cereus, Bacillus mycoides, and Bacillus thuringiensis), however
we needed to conduct further tests to determine which species were present in each
sample. The differentiating factors between samples were penicillin susceptibility,
motility, presence of ornithine decarboxylase, and endospore formation (seen via
crystal formation with a malachite stain).
Based on the dichotomous key for Group 1 Bacilli (Figure 2.10), we determined
the most likely species present in each sample. According to the UK Standards
for Microbiology Investigations, all of the Group 1 Bacilli are ubiquitous so it is no
surprise that they were found in our samples. However, it was interesting that every
sample with antibiotic activity was a species belonging to this group. It should also
be noted that one member of this group was absent from all our samples, Bacillus
thuringiensis. This is a possible candidate to act as a negative control in future
studies that may attempt to determine the molecule(s) that may be inhibiting S.
aureus growth.
Group 1 Bacilli are extremely similar, to the extent that our DNA sequencing was
unable to differentiate between them. Other studies have had comparable results,
including the work done by Ash, which showed that the 16S rRNA sequence in these
species varies by less than nine nucleotides70. Because of the similarities, it can be
hypothesized that most Group 1 Bacilli produce the same (or a similar) metabolite
that may have adverse effects on the growth of S. aureus.
The species in Group 1 Bacilli (sometimes referred to as the B. cereus group), all
seem to have pathologic consequences in humans in some cases, however they cause
significantly different presentations. B. anthracis is the cause of anthrax, likely the
most well-known condition caused by this group, for example71. Therefore, the
metabolite that is producing their antibiotic activity against S. aureus may also
produce some type of toxicity in humans.
Perhaps the most relevant “next step” in our research is to isolate and amplify the
molecule or molecules of interest for further testing. The levels naturally produced
by our soil bacteria were only sufficient to create zones of inhibition that were less
than 3 mm in diameter. This does not inherently imply they have a weak antibiotic
activity, as we cannot test for the concentration present until it is isolated. It is
possible that it may be a strong antibiotic when present at higher levels.
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AAppendix
1 Identification Tests
1.1 Gram Stain Protocol
1. Place a drop of TSB innoculated with unknown bacteria onto the center of a
clean slide.
2. Hold 6 inches over Bunsen burner until dry.
3. Place a drop of crystal violet stain onto the now-dried bacteria and let sit for
60 seconds.
4. Flush the slide with distilled water until runoff is clear.
5. Gently flush the slide with acetone or ethanol for 5 seconds.
6. Gently flush the slide with distilled water again.
7. Place a drop of safranin counter-strain onto the center of the slide.
8. Gently flush the slide with distilled water.
9. Hold the slide 6 inches over Bunsen burner until dry.
When viewed under a microscope, Gram positive bacteria will appear purple, while
Gram negative bacteria will appear red.
1.2 Phenyethyl Alcohol Agar (PEA) Protocol
Note: this protocol was completed using ThermoFisher Phenyethyl Alcohol Agar
solid medium. Components included in the media are listed below, as found
in ThermoFisher’s documentation (http://tools.thermofisher.com/content/sfs/
manuals/IFU454301.pdf).
Reagent Weight/Volume
Casein Peptone 15.0 g
Sodium Chloride 5.0 g
Soy Peptone 5.0 g




1. Use a lab scale to measure out 42.5 g of ThermoFisher PEA medium per 1000
mL of PEA agar required.
2. Add 1000 mL of water per 42.5 g of PEA medium to an empty beaker.
B3. Place beaker on a hot plate with stirrer turned to medium settings.
4. Add PEA medium to water slowly as it is stirred into a homogenous mixture.
5. Allow mixture to heat to a boil for 15 minutes (with stirrer on).
6. Cover the beaker and autoclave the mixture to sterilize.
7. Allow mixture to cool to 45-50°C and add defibrinated sheep’s blood (5% of
final volume).
8. Pour mixture into sterile plates or tubes as required while it is warm.
9. Allow plates and tubes to cool into solid media before use.
Plating Unknown Bacteria on PEA
1. Prepare TSB inoculate with unknown bacteria.
2. Using aseptic technique, streak unknown bacteria onto solidified PEA agar.
3. Incubate at given temperature.
Phenylethyl alcohol agar is selective for Gram positive cocci. Therefore growth of
unknown strain on PEA is evidence of Gram positive cocci. However, absence of
growth can be due to many factors and should not be used as evidence to rule out
that the unknown may be a Gram positive cocci.
1.3 MacConkey Agar Protocol
Note: this protocol was completed using ThermoFisher MacConkey Agar solid




Gelatin Pepton 17.0 g
Lactose 10.0 g
Sodium Chloride 5.0 g
Bile Salts 1.5 g
Casein Peptone 1.5 g
Meat Peptone 1.5 g
Neutral Red 30.0 mg




1. Use a lab scale to measure out 50.0 g of ThermoFisher MacConkey medium
per 1000 mL of MacConkey agar required.
2. Add 1000 mL of water per 50.0 g of MacConkey medium to an empty beaker.
3. Place beaker on a hot plate with stirrer turned to medium settings.
C4. Add MacConkey medium to water slowly as it is stirred into a homogenous
mixture.
5. Allow mixture to heat to a boil for 15 minutes (with stirrer on).
6. Cover the beaker and autoclave the mixture to sterilize.
7. Pour mixture into sterile plates or tubes as required while it is warm.
8. Allow plates and tubes to cool into solid media before use.
Plating Unknown Bacteria on MacConkey Agar
1. Prepare TSB inoculate with unknown bacteria.
2. Using aseptic technique, streak unknown bacteria onto solidified MacConkey
agar.
3. Incubate at given temperature.
MacConkey agar is selective for Gram negative bacilli. Visible growth indicates that
the unknown bacterium is likely a Gram negative bacillus. However, lack of growth
is not necessarily indicative that the unknown is not a Gram negative bacillus, as
other extraneous factors may prevent a given species from growing.
1.4 Spore Formation (and Malachite Staining) Protocol
1. Place a drop of TSB inoculated with unknown bacteria onto the center of a
clean slide.
2. Place a small piece of blotting paper or filter paper over the center of the slide.
3. Soak the blotting paper with malachite green stain.
4. Heat-dry by waving over a Bunsen burner (approximately 6 inches above the
flame).
5. Remove the blotting paper and rinse the slide with distilled water.
6. Place a drop of safranin counter-strain onto the center of the slide and let sit
for 60 seconds.
7. Gently flush the slide with distilled water until runoff is clear.
8. Using another piece of blotting paper, blot any excess moisture from the slide.
When viewed under a microscope, spores will stain green while the bacterial cells
will retain the safranin-red. Therefore, the presence of green on the slide indicates
that the unknown bacteria may be a spore-former.
1.5 Catalase Testing Protocol
1. Place a drop of TSB inoculated with unknown bacteria onto the center of a
clean slide.
2. Allow slide to dry for 5 minutes (wave slide over Bunsen burner to speed up
the process, being careful not to kill the bacteria due to excess heat).
3. Place a drop of hydrogen peroxide (3$) onto the center of the slide.
4. Watch for rapid formation of gas bubbles.
Rapid formation of gas bubbles indicates that the bacteria on the slide are break-
ing down hydrogen peroxide into water and oxygen quickly. In other words, these
bacteria are catalase positive.
D1.6 Mannitol Agar Protocol
Note: this protocol was completed using ThermoFisher Mannitol Salt Agar
solid medium. Components included in the media are listed below, as found
in ThermoFisher’s documentation (https://assets.thermofisher.com/TFS-Assets/
LSG/manuals/IFU1580.pdf).
Reagent Weight/Volume
Sodium Chloride 75.0 g
D-Mannitol 10.0 g
Casein Peptone 5.0 g
Meat Peptone 5.0 g
Beef Extract 1.0 g




1. Use a lab scale to measure out 110.0 g of ThermoFisher Mannitol medium per
1000 mL of Mannitol agar required.
2. Add 1000 mL of water per 110.0 g of Mannitol medium to an empty beaker.
3. Place beaker on a hot plate with stirrer turned to medium settings.
4. Add Mannitol medium to water slowly as it is stirred into a homogenous
mixture.
5. Allow mixture to heat to a boil for 15 minutes (with stirrer on).
6. Cover the beaker and autoclave the mixture to sterilize.
7. Pour mixture into sterile plates or tubes as required while it is warm.
8. Allow plates and tubes to cool into solid media before use.
Plating Unknown Bacteria on Mannitol
1. Prepare TSB inoculate with unknown bacteria.
2. Using aseptic technique, streak unknown bacteria onto solidified Mannitol
agar.
3. Incubate at given temperature.
Mannitol agar is a selective and differential growth medium. It selects for species of
bacteria that are able to grow with high salt concentrations, such as Staphylococcus
species.
However, it also contains an indicator that detects the acidic byproducts of man-
nitol fermentation. Therefore, species that are able to ferment mannitol, such as
Staphylococcus aureus will create a yellow zone in their immediate vicinity.
E2 Staphylococcus aureus Growth Data
Table 1: Absorbance readings at 600 nm.
Non-Shaker Shaker
Hours 25 C 37 C 43 C 25 C 37 C 43 C
0 -0.093 0.002 0.001 0.002 0.006 -0.001
1 0.004 0.002 0.002 0.002 0.001 -0.001
2 -0.001 0.002 0.001 0.001 0.002 -0.002
3 0.004 0.002 0.002 0.002 0.003 0.001
4 0.004 0.002 0.010 0.007 0.009 0.006
5 0.004 0.002 0.056 0.034 0.029 0.036
6 0.005 0.002 0.202 0.147 0.084 0.139
7 0.007 0.003 0.333 0.322 0.141 0.220
8 0.011 0.003 0.426 0.705 0.208 0.302
9 0.015 0.005 0.517 0.864 0.269 0.384
10 0.022 0.007 0.530 0.887 0.317 0.504
11 0.030 0.009 0.664 0.898 0.321 0.597
12 0.039 0.058 0.849 0.908 0.390 0.612
13 0.051 0.014 0.918 0.918 0.398 0.606
14 0.066 0.016 0.640 0.924 0.382 0.582
15 0.088 0.019 0.579 0.927 0.338 0.582
16 0.126 0.027 0.544 0.931 0.382 0.577
17 0.178 0.033 0.546 0.931 0.369 0.577
18 0.227 0.043 0.500 0.931 0.423 0.578
19 0.292 0.057 0.562 0.931 0.412 0.576
20 0.340 0.074 0.540 0.931 0.368 0.573
21 0.365 0.101 0.499 0.931 0.348 0.574
22 0.362 0.130 0.569 0.931 0.426 0.555
23 0.399 0.174 0.573 0.931 0.392 0.555
24 0.445 0.225 0.759 0.931 0.392 0.555
25 0.462 0.278 NA NA NA NA
26 0.476 0.338 NA NA NA NA
27 0.530 0.396 NA NA NA NA
28 0.568 0.457 NA NA NA NA
29 0.532 0.503 NA NA NA NA
30 0.558 0.534 NA NA NA NA
31 0.591 0.551 NA NA NA NA
32 0.584 0.570 NA NA NA NA
33 0.550 0.581 NA NA NA NA
34 0.509 0.602 NA NA NA NA
35 0.500 0.603 NA NA NA NA
36 0.531 0.613 NA NA NA NA
F3 Acinetobacter baumannii Growth Data
Table 2: Absorbance readings at 600 nm.
Non-Shaker Shaker
Hours 25 C 37 C 43 C 25 C 37 C 43 C
0 -0.063 0.002 -0.001 0.002 0.000 -0.002
1 0.001 0.003 0.000 0.002 0.000 -0.002
2 0.000 0.004 0.000 0.002 0.001 -0.003
3 0.004 0.006 0.002 0.002 0.006 -0.001
4 0.005 0.014 0.007 0.002 0.033 0.008
5 0.005 0.024 0.014 0.002 0.199 0.043
6 0.006 0.039 0.021 0.003 0.387 0.180
7 0.011 0.072 0.035 0.003 0.521 0.316
8 0.018 0.122 0.057 0.008 0.600 0.419
9 0.024 0.185 0.088 0.012 0.646 0.481
10 0.031 0.265 0.124 0.044 0.637 0.529
11 0.039 0.359 0.159 0.097 0.625 0.572
12 0.048 0.426 0.193 0.173 0.619 0.606
13 0.057 0.493 0.251 0.272 0.626 0.632
14 0.069 0.507 0.270 0.416 0.635 0.650
15 0.083 0.509 0.319 0.470 0.631 0.672
16 0.099 0.498 0.347 0.505 0.633 0.681
17 0.116 0.451 0.366 0.536 0.633 0.679
18 0.138 0.477 0.349 0.557 0.633 0.673
19 0.161 0.464 0.354 0.571 0.633 0.669
20 0.189 0.460 0.329 0.577 0.633 0.661
21 0.214 0.448 0.329 0.575 0.633 0.657
22 0.242 0.419 0.317 0.573 0.633 0.648
23 0.276 0.428 0.298 0.573 0.633 0.648
24 0.329 0.448 0.298 0.572 0.633 0.648
25 0.361 NA NA 0.571 NA NA
26 0.422 NA NA 0.571 NA NA
27 0.405 NA NA 0.572 NA NA
28 0.433 NA NA 0.571 NA NA
29 0.475 NA NA 0.570 NA NA
30 0.514 NA NA 0.570 NA NA
31 0.523 NA NA 0.570 NA NA
32 0.551 NA NA 0.571 NA NA
33 0.533 NA NA 0.572 NA NA
34 0.592 NA NA 0.571 NA NA
35 0.525 NA NA 0.572 NA NA
36 0.617 NA NA 0.571 NA NA
G4 DNA Sequencing Results
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M192 DNA Sequencing Analysis for Bacterial Isolates 
 
Species identification: 
Species identity is based on the unknown organism’s DNA sequence data for 16S ribosomal RNA gene and the 
comparison to the GenBank database at the National Center for Biotechnology Information (NCBI,www. 
ncbi.nlm.nih.gov). The PCR and DNA sequences were performed using standard bacterial DNA barcode primers: 357F 
and 1100R. The DNA sequences were analyzed using BLAST search at NCBI.  
 
Summary of Analysis  
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I5 National Centers for Environmental Information -
Weather Data
U.S. Department of Commerce Record of Climatological Observations
These data are quality controlled and may not be
identical to the original observations.
Generated on 07/24/2017
National Centers for Environmental Information
National Oceanic & Atmospheric Administration 151 Patton Avenue
National Environmental Satellite, Data, and Information Service Asheville, North Carolina 28801
Elev: 309 ft. Lat: 31.718° N Lon: 84.351° W





















































































 2015 10 1    0.18             
 2015 10 2    0.10             
 2015 10 3    0.04             
 2015 10 4    0.03             
 2015 10 5    0.07             
 2015 10 6    0.03             
 2015 10 7    T             
 2015 10 8    T             
 2015 10 9    0.00  0.0           
 2015 10 10    0.00  0.0           
 2015 10 11    0.02             
 2015 10 12    0.00  0.0           
 2015 10 13    0.00  0.0           
 2015 10 14    0.02             
 2015 10 15    0.00  0.0           
 2015 10 16    0.00  0.0           
 2015 10 17    0.00  0.0           
 2015 10 18    0.00  0.0           
 2015 10 19    0.00  0.0           
 2015 10 20    0.00  0.0           
 2015 10 21    0.00  0.0           
 2015 10 22    0.00  0.0           
 2015 10 23    0.00  0.0           
 2015 10 24    0.00  0.0           
 2015 10 25    0.00  0.0           
 2015 10 26    0.00  0.0           
 2015 10 27    0.14             
 2015 10 28    0.25             
 2015 10 29    0.08             
 2015 10 30    0.28             
 2015 10 31    T             
Summary     1.24  0.0   
The '*' flags in Preliminary indicate the data have not completed processing and qualitycontrol and may not be identical to the original observation
Empty, or blank, cells indicate that a data observation was not reported.
*Ground Cover: 1=Grass; 2=Fallow; 3=Bare Ground; 4=Brome grass; 5=Sod; 6=Straw mulch; 7=Grass muck; 8=Bare muck; 0=Unknown
"s" This data value failed one of NCDC's quality control tests.
"T" values in the Precipitation category above indicate a TRACE value was recorded.
"A" values in the Precipitation Flag or the Snow Flag column indicate a multiday total, accumulated since last measurement, is being used.
Data value inconsistency may be present due to rounding calculations during the conversion process from SI metric units to standard imperial units.
U.S. Department of Commerce Record of Climatological Observations
These data are quality controlled and may not be
identical to the original observations.
Generated on 07/24/2017
National Centers for Environmental Information
National Oceanic & Atmospheric Administration 151 Patton Avenue
National Environmental Satellite, Data, and Information Service Asheville, North Carolina 28801
Elev: 197 ft. Lat: 31.618° N Lon: 84.135° W





















































































 2015 10 1    0.48             
 2015 10 2    0.18             
 2015 10 3    0.58             
 2015 10 4    0.10             
 2015 10 5    0.10             
 2015 10 6    0.00  0.0           
 2015 10 7    0.00  0.0           
 2015 10 8    0.00  0.0           
 2015 10 9    0.00  0.0           
 2015 10 10    0.00  0.0           
 2015 10 11    0.00  0.0           
 2015 10 12    0.00  0.0           
 2015 10 13    0.00  0.0           
 2015 10 14    0.21             
 2015 10 15    0.00  0.0           
 2015 10 16    0.00  0.0           
 2015 10 17    0.00  0.0           
 2015 10 18    0.00  0.0           
 2015 10 19    0.00  0.0           
 2015 10 20    0.00  0.0           
 2015 10 21    0.00  0.0           
 2015 10 22    0.00  0.0           
 2015 10 23    0.00  0.0           
 2015 10 24    0.00  0.0           
 2015 10 25    0.00  0.0           
 2015 10 26    0.21             
 2015 10 27    0.21             
 2015 10 28    0.21             
 2015 10 29    0.00  0.0           
 2015 10 30    0.12             
 2015 10 31    0.00  0.0           
Summary     2.40  0.0   
The '*' flags in Preliminary indicate the data have not completed processing and qualitycontrol and may not be identical to the original observation
Empty, or blank, cells indicate that a data observation was not reported.
*Ground Cover: 1=Grass; 2=Fallow; 3=Bare Ground; 4=Brome grass; 5=Sod; 6=Straw mulch; 7=Grass muck; 8=Bare muck; 0=Unknown
"s" This data value failed one of NCDC's quality control tests.
"T" values in the Precipitation category above indicate a TRACE value was recorded.
"A" values in the Precipitation Flag or the Snow Flag column indicate a multiday total, accumulated since last measurement, is being used.
Data value inconsistency may be present due to rounding calculations during the conversion process from SI metric units to standard imperial units.
JU.S. Department of Commerce Record of Climatological Observations
These data are quality controlled and may not be
identical to the original observations.
Generated on 07/24/2017
National Centers for Environmental Information
National Oceanic & Atmospheric Administration 151 Patton Avenue
National Environmental Satellite, Data, and Information Service Asheville, North Carolina 28801
Elev: 247 ft. Lat: 31.629° N Lon: 84.225° W





















































































 2015 10 1    0.44             
 2015 10 2    0.75             
 2015 10 3                 
 2015 10 4                 
 2015 10 5    0.10             
 2015 10 6    0.02             
 2015 10 7    0.00  0.0           
 2015 10 8                 
 2015 10 9                 
 2015 10 10                 
 2015 10 11                 
 2015 10 12                 
 2015 10 13                 
 2015 10 14    0.20             
 2015 10 15                 
 2015 10 16                 
 2015 10 17                 
 2015 10 18                 
 2015 10 19                 
 2015 10 20                 
 2015 10 21                 
 2015 10 22                 
 2015 10 23                 
 2015 10 24                 
 2015 10 25                 
 2015 10 26                 
 2015 10 27                 
 2015 10 28    0.03             
 2015 10 29                 
 2015 10 30    0.23             
 2015 10 31    0.00  0.0           
Summary     1.77  0.0   
The '*' flags in Preliminary indicate the data have not completed processing and qualitycontrol and may not be identical to the original observation
Empty, or blank, cells indicate that a data observation was not reported.
*Ground Cover: 1=Grass; 2=Fallow; 3=Bare Ground; 4=Brome grass; 5=Sod; 6=Straw mulch; 7=Grass muck; 8=Bare muck; 0=Unknown
"s" This data value failed one of NCDC's quality control tests.
"T" values in the Precipitation category above indicate a TRACE value was recorded.
"A" values in the Precipitation Flag or the Snow Flag column indicate a multiday total, accumulated since last measurement, is being used.
Data value inconsistency may be present due to rounding calculations during the conversion process from SI metric units to standard imperial units.
U.S. Department of Commerce Record of Climatological Observations
These data are quality controlled and may not be
identical to the original observations.
Generated on 07/24/2017
National Centers for Environmental Information
National Oceanic & Atmospheric Administration 151 Patton Avenue
National Environmental Satellite, Data, and Information Service Asheville, North Carolina 28801
Elev: 180 ft. Lat: 31.534° N Lon: 84.149° W





















































































 2015 10 1 87 70 70 0.77             
 2015 10 2 81 67 67 0.07             
 2015 10 3 69 60 60 0.38             
 2015 10 4 67 59 60 0.03             
 2015 10 5 68 59 65 0.06             
 2015 10 6 69 62 62 0.04             
 2015 10 7 77 57 57 0.00             
 2015 10 8 82 56 56 0.00             
 2015 10 9 82 56 66 0.00             
 2015 10 10 86 65 69 0.00             
 2015 10 11 82 62 63 0.00             
 2015 10 12 68 56 56 0.00             
 2015 10 13 78 56 61 0.00             
 2015 10 14 81 57 57 0.17             
 2015 10 15 80 51 51 0.00             
 2015 10 16 84 51 53 0.00             
 2015 10 17 88 53 54 0.00             
 2015 10 18 75 48 48 0.00             
 2015 10 19 70 44 45 0.00             
 2015 10 20 71 45 48 0.00             
 2015 10 21 77 48 60 0.00             
 2015 10 22 81 57 58 0.00             
 2015 10 23 83 58 58 0.00             
 2015 10 24 84 57 57 0.00             
 2015 10 25 81 57 62 0.00             
 2015 10 26 79 62 69 0.00             
 2015 10 27 76 61 61 0.15             
 2015 10 28 70 61 70 0.04             
 2015 10 29 79 60 70 0.18             
 2015 10 30 82 55 55 0.04             
 2015 10 31 77 50 51 0.00             
Summary  78 57  1.93  0   
The '*' flags in Preliminary indicate the data have not completed processing and qualitycontrol and may not be identical to the original observation
Empty, or blank, cells indicate that a data observation was not reported.
*Ground Cover: 1=Grass; 2=Fallow; 3=Bare Ground; 4=Brome grass; 5=Sod; 6=Straw mulch; 7=Grass muck; 8=Bare muck; 0=Unknown
"s" This data value failed one of NCDC's quality control tests.
"T" values in the Precipitation category above indicate a TRACE value was recorded.
"A" values in the Precipitation Flag or the Snow Flag column indicate a multiday total, accumulated since last measurement, is being used.
Data value inconsistency may be present due to rounding calculations during the conversion process from SI metric units to standard imperial units.
KU.S. Department of Commerce Record of Climatological Observations
These data are quality controlled and may not be
identical to the original observations.
Generated on 07/24/2017
National Centers for Environmental Information
National Oceanic & Atmospheric Administration 151 Patton Avenue
National Environmental Satellite, Data, and Information Service Asheville, North Carolina 28801
Elev: 190 ft. Lat: 31.536° N Lon: 84.194° W





















































































 2015 10 1 85 70  0.01  0.0  0.0         
 2015 10 2 72 63  0.11    0.0         
 2015 10 3 69 61  0.02  0.0  0.0         
 2015 10 4 70 60  0.01  0.0  0.0         
 2015 10 5 70 64  0.01  0.0  0.0         
 2015 10 6 81 63  0.00  0.0  0.0         
 2015 10 7 84 57  0.00  0.0  0.0         
 2015 10 8 85 56  0.00  0.0  0.0         
 2015 10 9 88 66  0.00  0.0  0.0         
 2015 10 10 85 66  0.00  0.0  0.0         
 2015 10 11 70 62  0.00  0.0  0.0         
 2015 10 12 80 54  0.00  0.0  0.0         
 2015 10 13 83 60  0.20  0.0  0.0         
 2015 10 14 82 55  0.00  0.0  0.0         
 2015 10 15 86 50  0.00  0.0  0.0         
 2015 10 16 88 54  0.00  0.0  0.0         
 2015 10 17 78 53  0.00  0.0  0.0         
 2015 10 18 73 48  0.00  0.0  0.0         
 2015 10 19 73 45  0.00  0.0  0.0         
 2015 10 20 80 49  0.00  0.0  0.0         
 2015 10 21 82 54  0.00  0.0  0.0         
 2015 10 22 86 58  0.00  0.0  0.0         
 2015 10 23 86 58  0.00  0.0  0.0         
 2015 10 24 83 57  0.00  0.0  0.0         
 2015 10 25 82 63  0.00  0.0  0.0         
 2015 10 26 78 70  0.01  0.0  0.0         
 2015 10 27 71 62  0.14  0.0  0.0         
 2015 10 28 81 62  0.10  0.0  0.0         
 2015 10 29 84 58  0.04  0.0  0.0         
 2015 10 30 79 52  0.00  0.0  0.0         
 2015 10 31 83 50  T  0.0  0.0         
Summary  80 58  0.65  0.0   
The '*' flags in Preliminary indicate the data have not completed processing and qualitycontrol and may not be identical to the original observation
Empty, or blank, cells indicate that a data observation was not reported.
*Ground Cover: 1=Grass; 2=Fallow; 3=Bare Ground; 4=Brome grass; 5=Sod; 6=Straw mulch; 7=Grass muck; 8=Bare muck; 0=Unknown
"s" This data value failed one of NCDC's quality control tests.
"T" values in the Precipitation category above indicate a TRACE value was recorded.
"A" values in the Precipitation Flag or the Snow Flag column indicate a multiday total, accumulated since last measurement, is being used.
Data value inconsistency may be present due to rounding calculations during the conversion process from SI metric units to standard imperial units.
U.S. Department of Commerce Record of Climatological Observations
These data are quality controlled and may not be
identical to the original observations.
Generated on 07/24/2017
National Centers for Environmental Information
National Oceanic & Atmospheric Administration 151 Patton Avenue
National Environmental Satellite, Data, and Information Service Asheville, North Carolina 28801
Elev: 260 ft. Lat: 31.763° N Lon: 84.187° W





















































































 2015 10 1 85 69 70 0.00             
 2015 10 2 81 64 64 1.30             
 2015 10 3 68 58 59 0.53             
 2015 10 4 68 59 59 0.18             
 2015 10 5 69 59 66 0.07             
 2015 10 6 68 62 64 0.02             
 2015 10 7 77 57 59 0.00             
 2015 10 8 80 57 61 0.00             
 2015 10 9 82 61 74 0.00             
 2015 10 10 84 67 77 0.00             
 2015 10 11 77 62 68 0.00             
 2015 10 12 68 55 57 0.00             
 2015 10 13 77 57 62 0.00             
 2015 10 14 78 53 70 0.01             
 2015 10 15 83 50 51 0.00             
 2015 10 16 82 51 64 0.00             
 2015 10 17 88 50 65 0.00             
 2015 10 18 75 46 57 0.00             
 2015 10 19 69 42 46 0.00             
 2015 10 20 70 45 55 0.00             
 2015 10 21 77 52 62 0.00             
 2015 10 22 80 57 65 0.00             
 2015 10 23 83 58 66 0.00             
 2015 10 24 83 57 65 0.00             
 2015 10 25 80 61 66 0.00             
 2015 10 26 79 66 69 0.00             
 2015 10 27 76 58 59 0.43             
 2015 10 28 73 59 73 0.06             
 2015 10 29 77 58 65 0.08             
 2015 10 30 82 53 61 0.29             
 2015 10 31 76 49 59 0.00             
Summary  77 57  2.97  0   
The '*' flags in Preliminary indicate the data have not completed processing and qualitycontrol and may not be identical to the original observation
Empty, or blank, cells indicate that a data observation was not reported.
*Ground Cover: 1=Grass; 2=Fallow; 3=Bare Ground; 4=Brome grass; 5=Sod; 6=Straw mulch; 7=Grass muck; 8=Bare muck; 0=Unknown
"s" This data value failed one of NCDC's quality control tests.
"T" values in the Precipitation category above indicate a TRACE value was recorded.
"A" values in the Precipitation Flag or the Snow Flag column indicate a multiday total, accumulated since last measurement, is being used.
Data value inconsistency may be present due to rounding calculations during the conversion process from SI metric units to standard imperial units.
